Nice to see Bioshares back they have always had a bit of a soft spot for Phylogica, their ratings dropped from Class A to B but I assume that is largely just as a result of having the past partners walk - more partners &/or advancing a deal to a later stage and obviously that will lift back up.
Interesting to see the efficiency hurdle covered - that was always a suspect on assumption as to why some of those earlier partnerships didn't progress but was never mentioned as such - nice to see a bit of clarity there.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.000(0.00%) |
Mkt cap ! $787.4M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.39 | $1.33 | $54.32K | 40.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 655 | $1.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 4256 | 3 |
View Market Depth
| Last trade - 11.09am 21/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |